The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients

Benzer Materyaller

• Burden of Nonnucleoside Reverse Transcriptase Inhibitor Resistance in HIV-1-Infected Patients: A Systematic Review and Meta-Analysis
  Yazar:: Snedecor, Sonya J., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population
  Yazar:: Solem, Caitlyn T., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
  Yazar:: Bertoletti, Nicole, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Combination Nucleoside/ Nucleotide Reverse Transcriptase Inhibitors
  Yazar:: Akanbi, Maxwell O, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
  Yazar:: A. V. Kravchenko, ve diğerleri
  Baskı/Yayın Bilgisi: (2018-07-01)